243 related articles for article (PubMed ID: 15109123)
1. Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation.
Beyzadeoglu M; Oysul K; Dirican B; Arpaci F; Balkan A; Surenkok S; Pak Y
Tohoku J Exp Med; 2004 Apr; 202(4):255-63. PubMed ID: 15109123
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
[TBL] [Abstract][Full Text] [Related]
3. Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis.
Oya N; Sasai K; Tachiiri S; Sakamoto T; Nagata Y; Okada T; Yano S; Ishikawa T; Uchiyama T; Hiraoka M
Int J Hematol; 2006 Jan; 83(1):86-91. PubMed ID: 16443559
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation.
Beyzadeoglu M; Dirican B; Oysul K; Arpaci F; Pak Y
Haematologia (Budap); 2002; 32(1):25-30. PubMed ID: 12243552
[TBL] [Abstract][Full Text] [Related]
5. Dose response and factors related to interstitial pneumonitis after bone marrow transplant.
Sampath S; Schultheiss TE; Wong J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):876-84. PubMed ID: 16199317
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens.
Shinde A; Yang D; Frankel P; Liu A; Han C; Del Vecchio B; Schultheiss T; Cheng J; Li R; Kim D; Radany EH; Hui S; Somlo G; Rosenthal J; Stein A; Forman S; Wong JYC
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1025-1033. PubMed ID: 31421151
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
Gopal R; Ha CS; Tucker SL; Khouri IF; Giralt SA; Gajewski JL; Andersson BS; Cox JD; Champlin RE
Cancer; 2001 Oct; 92(7):1949-58. PubMed ID: 11745270
[TBL] [Abstract][Full Text] [Related]
8. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies.
Lohr F; Wenz F; Schraube P; Flentje M; Haas R; Zierhut D; Fehrentz D; Hunstein W; Wannenmacher M
Radiother Oncol; 1998 Jul; 48(1):45-51. PubMed ID: 9756171
[TBL] [Abstract][Full Text] [Related]
9. [Value of partial protection of lung tissue for prevention of radiation pneumonitis after total body irradiation].
Veshler Z; Slavin Sh
Gematol Transfuziol; 1991 Jan; 36(1):21-3. PubMed ID: 2065940
[TBL] [Abstract][Full Text] [Related]
10. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation.
Della Volpe A; Ferreri AJ; Annaloro C; Mangili P; Rosso A; Calandrino R; Villa E; Lambertenghi-Deliliers G; Fiorino C
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):483-8. PubMed ID: 11872296
[TBL] [Abstract][Full Text] [Related]
11. The balancing act: pneumonitis vs. relapse in cytoreductive regimens containing total body irradiation.
Shank B
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):261-2. PubMed ID: 8823285
[No Abstract] [Full Text] [Related]
12. Interstitial pneumonitis after hyperfractionated total body irradiation in HLA-matched T-depleted bone marrow transplantation.
Latini P; Aristei C; Aversa F; Checcaglini F; Maranzano E; Panizza BM; Perrucci E; Carotti A; Martelli MF
Int J Radiat Oncol Biol Phys; 1992; 23(2):401-5. PubMed ID: 1587763
[TBL] [Abstract][Full Text] [Related]
13. Effect of radiation dose rate and cyclophosphamide on pulmonary toxicity after total body irradiation in a mouse model.
Safwat A; Nielsen OS; El-Badawy S; Overgaard J
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):85-91. PubMed ID: 12118569
[TBL] [Abstract][Full Text] [Related]
14. Interstitial pneumonitis after total body irradiation: effect of partial lung shielding.
Weshler Z; Breuer R; Or R; Naparstek E; Pfeffer MR; Lowental E; Slavin S
Br J Haematol; 1990 Jan; 74(1):61-4. PubMed ID: 2178673
[TBL] [Abstract][Full Text] [Related]
15. Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation.
Buchali A; Feyer P; Groll J; Massenkeil G; Arnold R; Budach V
Radiother Oncol; 2000 Feb; 54(2):157-62. PubMed ID: 10699479
[TBL] [Abstract][Full Text] [Related]
16. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
Labar B; Bogdanić V; Nemet D; Mrsić M; Vrtar M; Grgić-Markulin L; Kalenić S; Vujasinović S; Presecki V; Jakić-Razumović J
Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
[TBL] [Abstract][Full Text] [Related]
17. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
[TBL] [Abstract][Full Text] [Related]
18. Total body irradiation in bone marrow transplantation: fractionated vs single dose. Acute toxicity and preliminary results.
Valls A; Grañena A; Carreras E; Ferrer E; Algara M
Bull Cancer; 1989; 76(8):797-804. PubMed ID: 2695178
[TBL] [Abstract][Full Text] [Related]
19. Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant.
Lawton CA; Barber-Derus S; Murray KJ; Casper JT; Ash RC; Gillin MT; Wilson JF
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):319-22. PubMed ID: 2666364
[TBL] [Abstract][Full Text] [Related]
20. melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: review of transplant-related mortality.
Hjiyiannakis P; Mehta J; Milan S; Powles R; Hinson J; Tait D
Leuk Lymphoma; 1997 May; 25(5-6):565-72. PubMed ID: 9250828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
